An Exploratory Study of XP21279 (With Lodosyn®) and Sinemet® in Parkinson's Disease Subjects

NCT00914602 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Sinemet 25-100 Oral Tablet
DRUG: XP21279
DRUG: Carbidopa Pill

Sponsor

XenoPort, Inc.